Search Results - "Camins, Antoni"

Refine Results
  1. 1
  2. 2

    Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: Therapeutic implications by Olloquequi, Jordi, Cornejo-Córdova, Elizabeth, Verdaguer, Ester, Soriano, Francesc X, Binvignat, Octavio, Auladell, Carme, Camins, Antoni

    Published in Journal of Psychopharmacology (01-03-2018)
    “…Neurological and psychiatric disorders are leading contributors to the global disease burden, having a serious impact on the quality of life of both patients…”
    Get full text
    Book Review Journal Article
  3. 3

    Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization by Sánchez-López, Elena, Ettcheto, Miren, Egea, Maria Antonia, Espina, Marta, Cano, Amanda, Calpena, Ana Cristina, Camins, Antoni, Carmona, Nuria, Silva, Amélia M, Souto, Eliana B, García, Maria Luisa

    Published in Journal of nanobiotechnology (27-03-2018)
    “…Memantine, drug approved for moderate to severe Alzheimer's disease, has not shown to be fully effective. In order to solve this issue, polylactic-co-glycolic…”
    Get full text
    Journal Article
  4. 4

    Metal-based nanoparticles as antimicrobial agents: an overview by Sánchez-López, Elena, Gomes, Daniela, Esteruelas, Gerard, Bonilla, Lorena, Lopez-Machado, Ana Laura, Galindo, Ruth, Cano, Amanda, Espina, Marta, Ettcheto, Miren, Camins, Antoni, Silva, Amélia M., Durazzo, Alessandra, Santini, Antonello, Garcia, Maria L., Souto, Eliana B.

    Published in Nanomaterials (Basel, Switzerland) (09-02-2020)
    “…Metal-based nanoparticles have been extensively investigated for a set of biomedical applications. According to the World Health Organization, in addition to…”
    Get full text
    Journal Article
  5. 5

    Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment by Camins, Antoni, Auladell, Carme, Olloquequi, Jordi, García, M. Luisa, Sánchez-López, Elena, Abad, Sonia, Ettcheto, Miren, Petrov, Dmitry, Folch, Jaume, Beas-Zarate, Carlos

    Published in Neural plasticity (01-01-2016)
    “…Alzheimer’s disease (AD) currently presents one of the biggest healthcare issues in the developed countries. There is no effective treatment capable of slowing…”
    Get full text
    Journal Article
  6. 6

    Current applications of nanoemulsions in cancer therapeutics by Sánchez-López, Elena, Guerra, Mariana, Dias-Ferreira, João, Lopez-Machado, Ana, Ettcheto, Miren, Cano, Amanda, Espina, Marta, Camins, Antoni, Garcia, Maria Luisa, Souto, Eliana B.

    Published in Nanomaterials (Basel, Switzerland) (31-05-2019)
    “…Nanoemulsions are pharmaceutical formulations composed of particles within a nanometer range. They possess the capacity to encapsulate drugs that are poorly…”
    Get full text
    Journal Article
  7. 7

    Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer's disease by Porquet, David, Griñán-Ferré, Christian, Ferrer, Isidre, Camins, Antoni, Sanfeliu, Coral, Del Valle, Jaume, Pallàs, Mercè

    Published in Journal of Alzheimer's disease (01-01-2014)
    “…The amyloid-β protein precursor/presenilin 1 (AβPP/PS1) mouse model of Alzheimer's disease (AD) has provided robust neuropathological hallmarks of familial…”
    Get more information
    Journal Article
  8. 8

    ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker by Manzine, Patricia Regina, Ettcheto, Miren, Cano, Amanda, Busquets, Oriol, Marcello, Elena, Pelucchi, Silvia, Di Luca, Monica, Endres, Kristina, Olloquequi, Jordi, Camins, Antoni, Cominetti, Márcia Regina

    Published in Biomedicine & pharmacotherapy (01-05-2019)
    “…[Display omitted] •APP cleavage by the α-secretase ADAM10 releases the soluble portion sAβPPα and prevents the generation of senile plaques.•Non-amyloidogenic…”
    Get full text
    Journal Article
  9. 9

    Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease by Pedrós, Ignacio, Petrov, Dmitry, Allgaier, Michael, Sureda, Francesc, Barroso, Emma, Beas-Zarate, Carlos, Auladell, Carme, Pallàs, Mercè, Vázquez-Carrera, Manuel, Casadesús, Gemma, Folch, Jaume, Camins, Antoni

    Published in Biochimica et biophysica acta (01-09-2014)
    “…The present study had focused on the behavioral phenotype and gene expression profile of molecules related to insulin receptor signaling in the hippocampus of…”
    Get full text
    Journal Article
  10. 10

    Understanding the Role of Hypoxia Inducible Factor During Neurodegeneration for New Therapeutics Opportunities by Merelli, Amalia, Rodríguez, Julio César García, Folch, Jaume, Regueiro, Marcelo R, Camins, Antoni, Lazarowski, Alberto

    Published in Current neuropharmacology (2018)
    “…Neurodegeneration (NDG) is linked with the progressive loss of neural function with intellectual and/or motor impairment. Several diseases affecting older…”
    Get full text
    Journal Article
  11. 11

    Protein tyrosine phosphatase 1B (PTP1B) as a potential therapeutic target for neurological disorders by Olloquequi, Jordi, Cano, Amanda, Sanchez-López, Elena, Carrasco, Marina, Verdaguer, Ester, Fortuna, Ana, Folch, Jaume, Bulló, Mònica, Auladell, Carme, Camins, Antoni, Ettcheto, Miren

    Published in Biomedicine & pharmacotherapy (01-11-2022)
    “…Protein tyrosine phosphatase 1B (PTP1B) is a typical member of the PTP family, considered a direct negative regulator of several receptor and…”
    Get full text
    Journal Article
  12. 12

    Epigallocatechin-3-gallate loaded PEGylated-PLGA nanoparticles: A new anti-seizure strategy for temporal lobe epilepsy by Cano, Amanda, Ettcheto, Miren, Espina, Marta, Auladell, Carmen, Calpena, Ana Cristina, Folch, Jaume, Barenys, Marta, Sánchez-López, Elena, Camins, Antoni, García, Maria Luisa

    Published in Nanomedicine (01-06-2018)
    “…Temporal lobe epilepsy is the most common type of pharmacoresistant epilepsy in adults. Epigallocatechin-3-gallate has aroused much interest because of its…”
    Get full text
    Journal Article
  13. 13
  14. 14

    From Inhalation to Neurodegeneration: Air Pollution as a Modifiable Risk Factor for Alzheimer's Disease by Olloquequi, Jordi, Díaz-Peña, Roberto, Verdaguer, Ester, Ettcheto, Miren, Auladell, Carme, Camins, Antoni

    “…Air pollution, a growing concern for public health, has been linked to various respiratory and cardiovascular diseases. Emerging evidence also suggests a link…”
    Get full text
    Journal Article
  15. 15

    Effects of Nutrition on Cognitive Function in Adults with or without Cognitive Impairment: A Systematic Review of Randomized Controlled Clinical Trials by Gutierrez, Laia, Folch, Alexandre, Rojas, Melina, Cantero, José Luis, Atienza, Mercedes, Folch, Jaume, Camins, Antoni, Ruiz, Agustín, Papandreou, Christopher, Bulló, Mònica

    Published in Nutrients (22-10-2021)
    “…New dietary approaches for the prevention of cognitive impairment are being investigated. However, evidence from dietary interventions is mainly from food and…”
    Get full text
    Journal Article
  16. 16

    The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations by Bonda, David J, BA, Lee, Hyoung-gon, PhD, Camins, Antoni, PhD, Pallàs, Mercè, PhD, Casadesus, Gemma, PhD, Smith, Mark A, Prof, Zhu, Xiongwei, PhD

    Published in Lancet neurology (01-03-2011)
    “…Summary Background Advances in gerontology have yielded crucial insights into the molecular and biochemical aspects of the ageing process. The sirtuin pathway,…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment by Poor, Saghar Rabiei, Ettcheto, Miren, Cano, Amanda, Sanchez-Lopez, Elena, Manzine, Patricia Regina, Olloquequi, Jordi, Camins, Antoni, Javan, Mohammad

    Published in Pharmaceuticals (Basel, Switzerland) (01-09-2021)
    “…Alzheimer’s disease (AD) is one of the most devastating brain disorders. Currently, there are no effective treatments to stop the disease progression and it is…”
    Get full text
    Journal Article
  19. 19

    Downregulation of canonical Wnt signaling in hippocampus of SAMP8 mice by Bayod, Sergi, Felice, Paolo, Andrés, Pol, Rosa, Paolo, Camins, Antoni, Pallàs, Mercè, Canudas, Anna-Maria

    Published in Neurobiology of aging (01-02-2015)
    “…Abstract In the adult brain, canonical Wnt (Wnt/β-catenin) signaling modulates neuronal function, hippocampal neurogenesis, and synaptic plasticity. Indeed,…”
    Get full text
    Journal Article
  20. 20

    Metformin restores cognitive dysfunction and histopathological deficits in an animal model of sporadic Alzheimer's disease by Rabieipoor, Saghar, Zare, Meysam, Ettcheto, Miren, Camins, Antoni, Javan, Mohammad

    Published in Heliyon (01-07-2023)
    “…Metformin has been introduced as a neuroprotective agent in recent years. Here we evaluate the therapeutic effects of metformin in sporadic mouse model of…”
    Get full text
    Journal Article